Home > Boards > US Listed > Biotechs > AXOVANT (AXON)

AXOVANT ANNOUNCES GLOBAL LICENSING AGREEMENT FOR AXO-AAV-OPMD PROGRAM

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
georgejjl Member Profile
 
Followed By 86
Posts 13,465
Boards Moderated 0
Alias Born 04/08/04
160x600 placeholder
georgejjl   Wednesday, 06/05/19 09:32:55 PM
Re: None
Post # of 363 
AXOVANT ANNOUNCES GLOBAL LICENSING AGREEMENT FOR AXO-AAV-OPMD PROGRAM FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY AND BROADER PLATFORM COLLABORATION WITH BENITEC BIOPHARMA

********************************************************************

Request for Trading Halt
In accordance with ASX Listing Rule 17.1, Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ:
BNTCW) (Benitec) requests a trading halt of its securities, effective immediately.
For the purposes of the trading halt, Benitec provides the following information:
(a) Benitec is seeking the trading halt as it expects to make an announcement to the ASX in relation to one of its
existing material contracts;
(b) Benitec requests the trading halt be put in place until the earlier of the commencement of trading on Tuesday 11
June 2019, or when an announcement is released to the market; and
(c) Benitec is not aware of any reason why the trading halt should not be granted or of any other information
necessary to inform the market about the trading halt.
Should you have any queries in relation to this trading halt request, please do not hesitate to contact me.
Yours faithfully
Oliver Kidd
Company Secretary


https://blt.irmau.com/irm/PDF/2071_0/TradingHalt

https://blt.irmau.com/irm/PDF/2069_0/Becomingasubstantialholder

What's up???

Good luck and GOD bless,

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist